A New Hope in the Treatment of Rett Syndrome: Trofinetide

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Anka Tıp Dergisi
Volume:6 Issue:3
A New Hope in the Treatment of Rett Syndrome: Trofinetide

A New Hope in the Treatment of Rett Syndrome: Trofinetide

Authors : Doğancan Sönmez

Pages : 134-135

Doi:10.38175/phnx.1465288

View : 69 | Download : 62

Publication Date : 2024-11-01

Article Type : Other Papers

Abstract :Trofinetide is a medication used to treat Rett Syndrome. It was approved by the United States in March 2023 for the treatment of Rett Syndrome in adults and children ages 2 and older. The drug is an N-terminal tripeptide derivative of insulin-like growth factor-1 (IGF-1) and is an oral, small molecule, synthetic analogue. The FDA\'s approval of trophinetide marks the first authorized treatment for Rett Syndrome.
Keywords : Rett Sendromu, Tedavi, Trofinetid

ORIGINAL ARTICLE URL

VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.

Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2025